Form 4: Cryoport CFO Exercises Stock Options, Acquires Shares

Cryoport's Chief Financial Officer, Robert Stefanovich, exercised stock options to acquire 53,334 shares of common stock at $4.80 per share.

Summary

• Robert Stefanovich, the Chief Financial Officer of Cryoport, Inc., exercised options to purchase 53,334 shares of common stock.
• The transaction occurred on December 11, 2024.
• The exercise price for the options was $4.80 per share.
• Following the transaction, Mr. Stefanovich directly owns 181,667 shares of Cryoport common stock.
• The options vested ratably over 48 months starting on January 18, 2015.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but indicates that the CFO is exercising his options, which can be seen as a sign of confidence.

Positives

• The exercise of options by a key executive can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the standard practice of granting stock options to key personnel.

Comparison to Industry Standards

• Stock option grants are a common form of compensation for executives in publicly traded companies, particularly in the biotechnology and life sciences sectors where Cryoport operates.
• The vesting schedule of 48 months is also a typical practice to incentivize long-term commitment from executives.
• Similar companies like BioLife Solutions and Thermo Fisher Scientific also utilize stock options as part of their executive compensation packages.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates confidence from a key executive.

Key Dates

Keywords

Cryoport, stock options, insider trading, Robert Stefanovich, CFO, equity, common stock, SEC Form 4